Leptin on peritoneal macrophages of patients with endometriosis. 2010

Meng-Hsing Wu, and Mei-Feng Huang, and Fong-Ming Chang, and Shaw-Jenq Tsai
Department of Obstetrics and Gynecology, College of Medicine, National Cheng Kung University, 1 University Road, Tainan, Taiwan.

OBJECTIVE The expression of cyclooxygenase (COX)-2 is considered as a marker of macrophage activation and has been implicated in the development of endometriosis. Leptin is an immunomodulator, which may also affect the development of endometriosis. However, how leptin contributes to these pathological processes has not been completely understood. The aim of this study was to investigate the effects of leptin on peritoneal macrophages and its relationship with endometriosis. METHODS Peritoneal fluid from 60 women of reproductive age was obtained while they underwent laparoscopy. Forty patients had endometriosis and 20 patients did not have endometriosis. The concentration of leptin in the peritoneal fluid and prostaglandin F(2alpha) levels was measured by ELISA, and the other protein expression using Western blot when peritoneal macrophages were stimulated with leptin. RESULTS Concentration of leptin in peritoneal fluid was increased in patients with endometriosis compared with disease-free normal control. Functional leptin receptor was present in peritoneal macrophages. Treatment of peritoneal macrophages with leptin induced COX-2 expression. Production of prostaglandin F(2alpha) by peritoneal macrophages was increased after leptin stimulation in women with endometriosis. CONCLUSIONS Elevated concentration of leptin in peritoneal fluid may contribute to the pathological process of endometriosis through activation of peritoneal macrophages.

UI MeSH Term Description Entries
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D004715 Endometriosis A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum. Endometrioma,Endometriomas,Endometrioses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001202 Ascitic Fluid The serous fluid of ASCITES, the accumulation of fluids in the PERITONEAL CAVITY. Peritoneal Effusion,Peritoneal Fluid,Ascitic Fluids,Effusion, Peritoneal,Fluid, Ascitic,Fluid, Peritoneal,Peritoneal Effusions,Peritoneal Fluids
D013624 Taiwan Country in eastern Asia, islands bordering the East China Sea, Philippine Sea, South China Sea, and Taiwan Strait, north of the Philippines, off the southeastern coast of China. The capital is Taipei. The alternate country name is Republic of China. Formosa,Republic of China
D015237 Dinoprost A naturally occurring prostaglandin that has oxytocic, luteolytic, and abortifacient activities. Due to its vasocontractile properties, the compound has a variety of other biological actions. PGF2,PGF2alpha,Prostaglandin F2,Prostaglandin F2alpha,9alpha,11beta-PGF2,Enzaprost F,Estrofan,PGF2 alpha,Prostaglandin F2 alpha,9alpha,11beta PGF2,F2 alpha, Prostaglandin,F2alpha, Prostaglandin,alpha, PGF2
D016215 Macrophage-Activating Factors Factors secreted by stimulated lymphocytes that prime macrophages to become nonspecifically cytotoxic to tumors. They also modulate the expression of macrophage cell surface Ia antigens. One MAF is INTERFERON-GAMMA. Other factors antigenically distinct from IFN-gamma have also been identified. Factors, Macrophage-Activating,Macrophage Activating Factors
D017472 Receptors, Interleukin-1 Cell surface receptors that are specific for INTERLEUKIN-1. Included under this heading are signaling receptors, non-signaling receptors and accessory proteins required for receptor signaling. Signaling from interleukin-1 receptors occurs via interaction with SIGNAL TRANSDUCING ADAPTOR PROTEINS such as MYELOID DIFFERENTIATION FACTOR 88. IL-1 Receptor,IL-1 Receptors,IL1 Receptor,Interleukin-1 Receptor,Interleukin-1 Receptors,Receptor, Interleukin-1,Receptors, IL-1,IL1 Receptors,Interleukin 1 Receptor,IL 1 Receptor,IL 1 Receptors,Interleukin 1 Receptors,Receptor, IL-1,Receptor, IL1,Receptor, Interleukin 1,Receptors, IL 1,Receptors, IL1,Receptors, Interleukin 1

Related Publications

Meng-Hsing Wu, and Mei-Feng Huang, and Fong-Ming Chang, and Shaw-Jenq Tsai
January 1984, American journal of obstetrics and gynecology,
Meng-Hsing Wu, and Mei-Feng Huang, and Fong-Ming Chang, and Shaw-Jenq Tsai
November 1989, Ceskoslovenska gynekologie,
Meng-Hsing Wu, and Mei-Feng Huang, and Fong-Ming Chang, and Shaw-Jenq Tsai
July 2000, The Journal of clinical endocrinology and metabolism,
Meng-Hsing Wu, and Mei-Feng Huang, and Fong-Ming Chang, and Shaw-Jenq Tsai
June 1989, Asia-Oceania journal of obstetrics and gynaecology,
Meng-Hsing Wu, and Mei-Feng Huang, and Fong-Ming Chang, and Shaw-Jenq Tsai
May 2001, Ginekologia polska,
Meng-Hsing Wu, and Mei-Feng Huang, and Fong-Ming Chang, and Shaw-Jenq Tsai
February 2005, Archives of gynecology and obstetrics,
Meng-Hsing Wu, and Mei-Feng Huang, and Fong-Ming Chang, and Shaw-Jenq Tsai
May 1988, The Journal of clinical endocrinology and metabolism,
Meng-Hsing Wu, and Mei-Feng Huang, and Fong-Ming Chang, and Shaw-Jenq Tsai
October 2021, International journal of molecular sciences,
Meng-Hsing Wu, and Mei-Feng Huang, and Fong-Ming Chang, and Shaw-Jenq Tsai
October 2008, Journal of reproductive immunology,
Meng-Hsing Wu, and Mei-Feng Huang, and Fong-Ming Chang, and Shaw-Jenq Tsai
January 1987, Contributions to gynecology and obstetrics,
Copied contents to your clipboard!